Women who carry pathogenic BRCA1 variants are particularly likely to develop breast cancer (BC) and ovarian cancer (OC), with a 45–79% and 39–48% chance, respectively [7,8,9,10,11]. This evidence concerns the gene BRCA1 and ovarian cancer.